Unknown OBSERVATIONAL NCT05789498

Investigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients

Investigating the Biomarkers in Tumor Microenvironment and Peripheral Blood Microenvironment to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients

Sponsor: Zhao Jun

Conditions Esophageal Cancer Lung Cancer

Interventions In vitro stimulation of Pbmc with tumor antigen nanoparticles

Updated 4 times since 2023 Last updated: Mar 16, 2023 Started: Feb 12, 2023 Primary completion: Mar 30, 2024 Completion: Jun 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05789498, this observational or N/A phase trial focuses on Esophageal Cancer and Lung Cancer and remains ongoing. Sponsored by Zhao Jun, it has been updated 4 times since 2023, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

4 versions recorded

Apr 2025 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Apr 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Apr 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Feb 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zhao Jun

Data source: The First Affiliated Hospital of Soochow University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Suzhou, China